Utilizing genomic information for precision medicine

Home to many well know high-tech companies, South Korea is famous for its technology leadership. GC, South Korea’s largest life-sciences company, is a multi-faceted healthcare company that employs many cutting-edge technologies.

GC Genome is able to leverage South Korea’s intellectual capital across life sciences to develop advancements in precision medicine. Their core technology is already used routinely for annual screening—with thousands of patients tested since early 2022.

Genece has exclusively obtained license of GC Genome’s cancer screening technology for North America and is actively utilizing their technical and commercial advancements to catalyze our product development.